As the COVID-19 pandemic
continues, the relationship between pharma sales reps and physicians is
starting to settle into a new normal. Digital interactions are on the rise, and
doctors are increasingly welcoming contact with reps, according to ongoing polling
from healthcare consultancy ZoomRx.
The group began asking doctors
weekly about the impact of COVID-19 on their practices beginning March 14,
fielding its most recent survey of similar questions a period ending May
5.
In the latest survey—its
fifth—78% of physicians said they want to maintain some contact with pharma
reps, up from just 64% when ZoomRx originally began polling doctors. While most
physicians (43%) prefer a similar level of contact as before the pandemic
began, 14% would actually like more outreach from pharma.